LeMaitre Vascular Reports Third-Quarter Revenue of $67.97 Million, EPS of $0.65
Third-quarter net sales rose 11% year over year, while net income declined. The company cited higher average selling prices and unit volumes, plus international Artegraft sales following its European launch.
LeMaitre Vascular’s third-quarter net sales rose 11% year over year, while net income declined. Growth reflected higher average selling prices and unit volumes, along with international Artegraft sales following its European launch; higher operating expenses and the prior-year Employee Retention Cr…